Aptadel Therapeutics launches with a $2.1M in seed financing

by Professional Newco

Aptadel Therapeutics, a pre-clinical biomedical company focused on developing a RNA-based platform of targeted therapy delivery to treat cancer, has announced the closing of a $2.1M in seed financing....

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

CRB Health Tech realiza el primer cierre...

by CRB Inverbío SA SGECR

Con la incorporación de Sanitas y las suscripciones ya firmadas con a...

Photos Stream